{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:47Z","timestamp":1792807547530,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005672","name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","doi-asserted-by":"publisher","award":["71\/031.898\/2022"],"award-info":[{"award-number":["71\/031.898\/2022"]}],"id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11274-023-03530-6","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T03:31:55Z","timestamp":1675222315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae: a patent review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-9109","authenticated-orcid":false,"given":"Gleyce Hellen de Almeida","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-3313","authenticated-orcid":false,"given":"Luana","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-4984","authenticated-orcid":false,"given":"Alexandre Ribeiro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-0915","authenticated-orcid":false,"given":"Simone","family":"Simionatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"3530_CR1","unstructured":"Akers-Rodriguez S, Balkovec J, Bensen D, et al (2019) Compositions and methods for the treatment of bacterial infections. WO2019126353A2"},{"key":"3530_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/13543776.2020.1851679","volume":"30","author":"G Annunziato","year":"2020","unstructured":"Annunziato G, Costantino G (2020) Antimicrobial peptides (AMPs): a patent review (2015\u20132020). Expert Opin Ther Pat 30:931\u2013947. https:\/\/doi.org\/10.1080\/13543776.2020.1851679","journal-title":"Expert Opin Ther Pat"},{"key":"3530_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"A Bahar","year":"2013","unstructured":"Bahar A, Ren D (2013) Antimicrobial peptides. Pharmaceuticals 6:1543\u20131575. https:\/\/doi.org\/10.3390\/ph6121543","journal-title":"Pharmaceuticals"},{"key":"3530_CR4","unstructured":"Balkovec JM, Blizzard T, Borchardt A, et al (2020) Compositions and methods for the treatment of bacterial infections. WO2020014501A1"},{"key":"3530_CR5","doi-asserted-by":"publisher","first-page":"11691","DOI":"10.3390\/ijms222111691","volume":"22","author":"A Bin Hafeez","year":"2021","unstructured":"Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y (2021) Antimicrobial peptides: an update on classifications and databases. IJMS 22:11691. https:\/\/doi.org\/10.3390\/ijms222111691","journal-title":"IJMS"},{"key":"3530_CR6","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3389\/fmicb.2019.03097","volume":"10","author":"MH Cardoso","year":"2020","unstructured":"Cardoso MH, Orozco RQ, Rezende SB et al (2020) Computer-aided design of antimicrobial peptides: are we generating effective drug candidates? Front Microbiol 10:3097. https:\/\/doi.org\/10.3389\/fmicb.2019.03097","journal-title":"Front Microbiol"},{"key":"3530_CR7","unstructured":"Cooper M, Blaskovich M, Gallardo-Goday A, et al (2019) Peptide antibiotics. WO2019084628A1"},{"key":"3530_CR8","doi-asserted-by":"publisher","unstructured":"Da Silva KE, Thi Nguyen TN, Boinett CJ, et al (2020) Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations. Int J Med Microbiol 310:151448. https:\/\/doi.org\/10.1016\/j.ijmm.2020.151448","DOI":"10.1016\/j.ijmm.2020.151448"},{"key":"3530_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/antibiotics10030284","volume":"10","author":"E De La Cadena","year":"2021","unstructured":"De La Cadena E, Mojica MF, Garc\u00eda-Betancur JC et al (2021) Molecular analysis of polymyxin resistance among carbapenemase-producing Klebsiella pneumoniae in Colombia. Antibiotics 10:284. https:\/\/doi.org\/10.3390\/antibiotics10030284","journal-title":"Antibiotics"},{"key":"3530_CR10","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ et al (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33:e00181-e219. https:\/\/doi.org\/10.1128\/CMR.00181-19","journal-title":"Clin Microbiol Rev"},{"key":"3530_CR11","doi-asserted-by":"publisher","unstructured":"Deshayes C, Arafath MdN, Apaire-Marchais V, Roger E (2022) Drug Delivery systems for the oral administration of antimicrobial peptides: promising tools to treat infectious diseases. Front Med Technol 3:778645. https:\/\/doi.org\/10.3389\/fmedt.2021.778645","DOI":"10.3389\/fmedt.2021.778645"},{"key":"3530_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","volume":"4","author":"MA Farha","year":"2019","unstructured":"Farha MA, Brown ED (2019) Drug repurposing for antimicrobial discovery. Nat Microbiol 4:565\u2013577. https:\/\/doi.org\/10.1038\/s41564-019-0357-1","journal-title":"Nat Microbiol"},{"key":"3530_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/jac\/dkaa560","volume":"76","author":"MR Fel\u00edcio","year":"2021","unstructured":"Fel\u00edcio MR, Silveira GGOS, Oshiro KGN et al (2021) Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens. J Antimicrob Chemother 76:1174\u20131186. https:\/\/doi.org\/10.1093\/jac\/dkaa560","journal-title":"J Antimicrob Chemother"},{"key":"3530_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.joi.2007.06.001","volume":"1","author":"Y-J Han","year":"2007","unstructured":"Han Y-J (2007) Measuring industrial knowledge stocks with patents and papers. J Informetr 1:269\u2013276. https:\/\/doi.org\/10.1016\/j.joi.2007.06.001","journal-title":"J Informetr"},{"key":"3530_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40121-020-00395-2","volume":"10","author":"GT Hansen","year":"2021","unstructured":"Hansen GT (2021) Continuous evolution: perspective on the epidemiology of carbapenemase resistance among enterobacterales and other gram-negative bacteria. Infect Dis Ther 10:75\u201392. https:\/\/doi.org\/10.1007\/s40121-020-00395-2","journal-title":"Infect Dis Ther"},{"key":"3530_CR16","unstructured":"Huang E, Moon S, Smeltzer M, Meeker D (2019) Linear lipopeptide paenipeptins and methods of using the same. WO2019028463A1"},{"key":"3530_CR17","unstructured":"Kao C (2017) Bactericidal peptides and uses thereof. WO2017172929A1"},{"key":"3530_CR18","doi-asserted-by":"publisher","unstructured":"Kao C, Lin X, Yi G, et al (2016) Cathelicidin antimicrobial peptides with reduced activation of toll-like receptor signaling have potent bactericidal activity against colistin-resistant bacteria. mBio 7:e01418\u201316. https:\/\/doi.org\/10.1128\/mBio.01418-16","DOI":"10.1128\/mBio.01418-16"},{"key":"3530_CR19","unstructured":"Kao C, Prieto AC, Rowe-Magnus D (2019) Bactericidal peptides and uses thereof. WO2019200378A1"},{"key":"3530_CR20","unstructured":"Kraus CN, Otvos L (2020a) Antibacterial peptide monomers and combinations for co-therapy. WO2020a014642A2"},{"key":"3530_CR21","unstructured":"Kraus CN, Otvos L (2020b) Antibacterial peptides and combinations for co-therapy. US2020b323950A1"},{"key":"3530_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nbt.2020.10.006","volume":"60","author":"J Krauss","year":"2021","unstructured":"Krauss J, Kuttenkeuler D (2021) When to file for a patent? The scientist\u2019s perspective. N Biotechnol 60:124\u2013129. https:\/\/doi.org\/10.1016\/j.nbt.2020.10.006","journal-title":"N Biotechnol"},{"key":"3530_CR23","unstructured":"Kui Z, Jianzhong S, Shuangyang D, et al (2018) Linear antibacterial oligopeptide SLAP-S25 and application thereof. CN108467424A"},{"key":"3530_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/SHK.0b013e3181819cb8","volume":"30","author":"AS Levin","year":"2008","unstructured":"Levin AS, Oliveira MS (2008) The challenge of multidrug resistance: the treatment of Gram-negative rod infections. Shock 30:30\u201333. https:\/\/doi.org\/10.1097\/SHK.0b013e3181819cb8","journal-title":"Shock"},{"key":"3530_CR25","unstructured":"Li J, Velkov T, Nation RL, Thompson PE (2010) Antimicrobial compounds. WO2010130007A1"},{"key":"3530_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12866-022-02462-9","volume":"22","author":"J Li","year":"2022","unstructured":"Li J, Tang M, Xia F et al (2022) Emergence of polymyxin B-heteroresistant hypervirulent Klebsiella pneumoniae from an individual in the community with asymptomatic bacteriuria. BMC Microbiol 22:47. https:\/\/doi.org\/10.1186\/s12866-022-02462-9","journal-title":"BMC Microbiol"},{"key":"3530_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"Y-Y Liu","year":"2016","unstructured":"Liu Y-Y, Wang Y, Walsh TR et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161\u2013168. https:\/\/doi.org\/10.1016\/S1473-3099(15)00424-7","journal-title":"Lancet Infect Dis"},{"key":"3530_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcimb.2018.00004","volume":"8","author":"RM Martin","year":"2018","unstructured":"Martin RM, Bachman MA (2018) Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol 8:4. https:\/\/doi.org\/10.3389\/fcimb.2018.00004","journal-title":"Front Cell Infect Microbiol"},{"key":"3530_CR29","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1021\/acs.jmedchem.7b01064","volume":"60","author":"SH Moon","year":"2017","unstructured":"Moon SH, Zhang X, Zheng G et al (2017) Novel linear lipopeptide paenipeptins with potential for eradicating biofilms and sensitizing gram-negative bacteria to rifampicin and clarithromycin. J Med Chem 60:9630\u20139640. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01064","journal-title":"J Med Chem"},{"key":"3530_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF (2021) Trends in peptide drug discovery. Nat Rev Drug Discov 20:309\u2013325. https:\/\/doi.org\/10.1038\/s41573-020-00135-8","journal-title":"Nat Rev Drug Discov"},{"key":"3530_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/antibiotics10080981","volume":"10","author":"F Nainu","year":"2021","unstructured":"Nainu F, Permana AD, Djide NJN et al (2021) Pharmaceutical approaches on antimicrobial resistance: prospects and challenges. Antibiotics 10:981. https:\/\/doi.org\/10.3390\/antibiotics10080981","journal-title":"Antibiotics"},{"key":"3530_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","volume":"41","author":"S Navon-Venezia","year":"2017","unstructured":"Navon-Venezia S, Kondratyeva K, Carattoli A (2017) Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 41:252\u2013275. https:\/\/doi.org\/10.1093\/femsre\/fux013","journal-title":"FEMS Microbiol Rev"},{"key":"3530_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ijantimicag.2011.01.003","volume":"37","author":"E Ostorhazi","year":"2011","unstructured":"Ostorhazi E, Holub MC, Rozgonyi F et al (2011) Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved. Int J Antimicrob Agents 37:480\u2013484. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.01.003","journal-title":"Int J Antimicrob Agents"},{"key":"3530_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fchem.2018.00309","volume":"6","author":"L Otvos Jr","year":"2018","unstructured":"Otvos L Jr, Ostorhazi E, Szabo D et al (2018) Synergy between proline-rich antimicrobial peptides and small molecule antibiotics against selected gram-negative pathogens in vitro and in vivo. Front Chem 6:309. https:\/\/doi.org\/10.3389\/fchem.2018.00309","journal-title":"Front Chem"},{"key":"3530_CR35","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71: https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"3530_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/biomedicines9101381","volume":"9","author":"AA Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez AA, Otero-Gonz\u00e1lez A, Ghattas M, St\u00e4ndker L (2021) Discovery, optimization, and clinical application of natural antimicrobial peptides. Biomedicines 9:1381. https:\/\/doi.org\/10.3390\/biomedicines9101381","journal-title":"Biomedicines"},{"key":"3530_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/ciw805","volume":"64","author":"LJ Rojas","year":"2016","unstructured":"Rojas LJ, Salim M, Cober E et al (2016) Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis 64:711\u2013718. https:\/\/doi.org\/10.1093\/cid\/ciw805","journal-title":"Clin Infect Dis"},{"key":"3530_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/07388551.2021.1874283","volume":"41","author":"MR Serafini","year":"2021","unstructured":"Serafini MR, Santos VV, Torres BGS et al (2021) A patent review of antibiofilm fungal drugs (2002-present). Crit Rev Biotechnol 41:229\u2013248. https:\/\/doi.org\/10.1080\/07388551.2021.1874283","journal-title":"Crit Rev Biotechnol"},{"key":"3530_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics13040438","volume":"13","author":"J Shi","year":"2021","unstructured":"Shi J, Chen C, Wang D et al (2021) Amphipathic peptide antibiotics with potent activity against multidrug-resistant pathogens. Pharmaceutics 13:438. https:\/\/doi.org\/10.3390\/pharmaceutics13040438","journal-title":"Pharmaceutics"},{"key":"3530_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41586-018-0483-6","volume":"561","author":"PA Smith","year":"2018","unstructured":"Smith PA, Koehler MFT, Girgis HS et al (2018) Optimized arylomycins are a new class of Gram-negative antibiotics. Nature 561:189\u2013194. https:\/\/doi.org\/10.1038\/s41586-018-0483-6","journal-title":"Nature"},{"key":"3530_CR41","unstructured":"Smith PA, Murray JM, Koehler MFT, Heise CE (2020) Peptide antibiotic complexes and methods of use thereof. CN111386283A"},{"key":"3530_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10096-020-04053-w","volume":"40","author":"R Soman","year":"2021","unstructured":"Soman R, Bakthavatchalam YD, Nadarajan A et al (2021) Is it time to move away from polymyxins?: evidence and alternatives. Eur J Clin Microbiol Infect Dis 40:461\u2013475. https:\/\/doi.org\/10.1007\/s10096-020-04053-w","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3530_CR43","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","volume":"5","author":"M Song","year":"2020","unstructured":"Song M, Liu Y, Huang X et al (2020) A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens. Nat Microbiol 5:1040\u20131050. https:\/\/doi.org\/10.1038\/s41564-020-0723-z","journal-title":"Nat Microbiol"},{"key":"3530_CR44","unstructured":"Steckback JD (2019) Engineered antimicrobial amphiphilic peptides and methods of use. CN110582507A"},{"key":"3530_CR45","unstructured":"Steckbeck JD, Dobbins D, Huang D (2022) Intravenous administration of engineered antimicrobial amphiphilic peptides. WO2022173981A1"},{"key":"3530_CR46","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.4155\/fmc-2020-0225","volume":"12","author":"LJ Stephens","year":"2020","unstructured":"Stephens LJ, Werrett MV, Sedgwick AC et al (2020) Antimicrobial innovation: a current update and perspective on the antibiotic drug development pipeline. Future Med Chem 12:2035\u20132065. https:\/\/doi.org\/10.4155\/fmc-2020-0225","journal-title":"Future Med Chem"},{"key":"3530_CR47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb.13.39","volume":"8","author":"T Velkov","year":"2013","unstructured":"Velkov T, Roberts KD, Nation RL et al (2013) Pharmacology of polymyxins: new insights into an \u2018old\u2019 class of antibiotics. Future Microbiol 8:711\u2013724. https:\/\/doi.org\/10.2217\/fmb.13.39","journal-title":"Future Microbiol"},{"key":"3530_CR48","unstructured":"Walensky LD, Mourtada R (2020) Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections. US2020207821A1"},{"key":"3530_CR49","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/ijms17050603","volume":"17","author":"S Wang","year":"2016","unstructured":"Wang S, Zeng X, Yang Q, Qiao S (2016) Antimicrobial peptides as potential alternatives to antibiotics in food animal industry. IJMS 17:603. https:\/\/doi.org\/10.3390\/ijms17050603","journal-title":"IJMS"},{"key":"3530_CR50","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.3390\/ijerph17176278","volume":"17","author":"G Wang","year":"2020","unstructured":"Wang G, Zhao G, Chao X et al (2020) The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. IJERPH 17:6278. https:\/\/doi.org\/10.3390\/ijerph17176278","journal-title":"IJERPH"},{"key":"3530_CR51","unstructured":"World Intellectual Property (2022) WIP publishing international patent classification"},{"key":"3530_CR52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41579-019-0315-1","volume":"18","author":"KL Wyres","year":"2020","unstructured":"Wyres KL, Lam MMC, Holt KE (2020) Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol 18:344\u2013359. https:\/\/doi.org\/10.1038\/s41579-019-0315-1","journal-title":"Nat Rev Microbiol"},{"key":"3530_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tim.2020.04.012","volume":"29","author":"X Yang","year":"2021","unstructured":"Yang X, Dong N, Chan EW-C et al (2021) Carbapenem resistance-encoding and virulence-encoding conjugative plasmids in Klebsiella pneumoniae. Trends Microbiol 29:65\u201383. https:\/\/doi.org\/10.1016\/j.tim.2020.04.012","journal-title":"Trends Microbiol"},{"key":"3530_CR54","doi-asserted-by":"publisher","first-page":"8243","DOI":"10.3390\/ijms22158243","volume":"22","author":"D-G You","year":"2021","unstructured":"You D-G, Lee H-R, Kim H-K et al (2021) A novel peptide derived from the transmembrane domain of Romo1 is a promising candidate for sepsis treatment and multidrug-resistant bacteria. IJMS 22:8243. https:\/\/doi.org\/10.3390\/ijms22158243","journal-title":"IJMS"},{"key":"3530_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40779-021-00343-2","volume":"8","author":"Q-Y Zhang","year":"2021","unstructured":"Zhang Q-Y, Yan Z-B, Meng Y-M et al (2021a) Antimicrobial peptides: mechanism of action, activity and clinical potential. Military Med Res 8:48. https:\/\/doi.org\/10.1186\/s40779-021-00343-2","journal-title":"Military Med Res"},{"key":"3530_CR56","doi-asserted-by":"publisher","first-page":"e01231","DOI":"10.1128\/Spectrum.01231-21","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Lin Y, Zhang X et al (2021b) Combining colistin with furanone C-30 rescues colistin resistance of gram-negative bacteria in vitro and in vivo. Microbiol Spectr 9:e01231-e1321. https:\/\/doi.org\/10.1128\/Spectrum.01231-21","journal-title":"Microbiol Spectr"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-023-03530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-023-03530-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-023-03530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:51:09Z","timestamp":1744210269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-023-03530-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3530"],"URL":"https:\/\/doi.org\/10.1007\/s11274-023-03530-6","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"86"}}